CoChat

RETRACTED: Pioglitazone improves lipid and insulin levels in overweight rats on a high cholesterol and fructose diet by decreasing hepatic inflammation

Open access
Collino, Massimo, Aragno, Manuela, Castiglia, Sara, Miglio, Gianluca, Tomasinelli, Chiara, Boccuzzi, Giuseppe, Thiemermann, Christoph, Fantozzi, Roberto · 2010 · British Journal of Pharmacology
Cited by 106

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

Abstract

Background and purpose: Nutrient overload leads to obesity and insulin resistance. Pioglitazone, a selective peroxisome proliferator‐activated receptor (PPAR)γ agonist, is currently used to manage insulin resistance, but the specific molecular mechanisms activated by PPARγ are not yet fully understood. Recent studies suggest the involvement of suppressor of cytokine signalling (SOCS)‐3 in the pathogenesis of insulin resistance. This study aimed to investigate the hepatic signalling pathway activated by PPARγ activation in a non‐genetic insulin‐resistant animal model. Experimental approach: Male Wistar rats were maintained on a high‐cholesterol fructose (HCF) diet for 15 weeks. Pioglitazone (3 mg·kg−1) was administered orally for the last 4 weeks of this diet. At the end of the treatment, serum was collected for biochemical analysis. Levels of PPARγ, SOCS‐3, pro‐inflammatory markers, insulin receptor substrate‐2 and Akt/glycogen synthase kinase‐3β phosphorylation were assesed in rat liver. Key results: Rats fed the HCF diet exhibited hyperlipidemia, hyperinsulinemia, impaired glucose tolerance and insulin resistance. Pioglitazone administration evoked a significant improvement in lipid metabolism and insulin responsiveness. This was accompanied by reduced hepatic expression of SOCS‐3, interleukin‐6, tumour necrosis factor‐α and markers of neutrophil infiltration. Diet‐induced PPARγ expression was unaffected by the pioglitazone treatment. Conclusion and implications: Chronic pioglitazone administration reduced hepatic inflammatory responses in rats fed a HCF diet. These effects were associated with changes in hepatic expression of SOCS‐3, which may be a crucial link between the reduced local inflammation and the improved insulin signalling. This article is commented on by Chatterjee, pp. 1889–1891 of this issue. To view this commentary visit http://dx.doi.org/10.1111/j.1476‐5381.2010.00739.x

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1476-5381.2010.00671.xThis paper is marked retracted.

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 11 references

Cited by

See all 106

Metadata

Authors
Collino, M., Aragno, M., Castiglia, S., Miglio, G., Tomasinelli, C., Boccuzzi, G., Thiemermann, C., & Fantozzi, R.
Venue
British Journal of Pharmacology
Publisher
Wiley
Published
2010-03-08
Volume
160
Issue
8
Pages
1892-1902
ISSN
  • 0007-1188 (ISSN-L)
  • 1476-5381
OpenAlex
W1505664810
Cited by
106
References
11
FWCI
2.72
Type
journal article
Language
en
Status
Retracted
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: RETRACTED: Pioglitazone improves lipid and insulin levels in overweight rats on a high cholesterol and fructose diet by decreasing hepatic inflammation. https://app.cochat.ai/papers/10.1111/j.1476-5381.2010.00671.x
The paper
Collino, M., Aragno, M., Castiglia, S., Miglio, G., Tomasinelli, C., Boccuzzi, G., Thiemermann, C., & Fantozzi, R. (2010). RETRACTED: Pioglitazone improves lipid and insulin levels in overweight rats on a high cholesterol and fructose diet by decreasing hepatic inflammation. British Journal of Pharmacology. https://doi.org/10.1111/j.1476-5381.2010.00671.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.